
Deranged regulatory T-cells and transforming growth factor-β1 levels in type 1 diabetes patients with associated autoimmune diseases
Author(s) -
Navchetan Kaur,
RW Minz,
Sanjay Kumar Bhadada,
Devi Dayal,
Jagdeep Singh,
Shashi Anand
Publication year - 2017
Publication title -
journal of postgraduate medicine/journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/jpgm.jpgm_608_16
Subject(s) - medicine , autoimmune disease , disease , transforming growth factor , foxp3 , immunology , graves' disease , autoantibody , type 1 diabetes , diabetes mellitus , autoimmunity , gastroenterology , endocrinology , immune system , antibody
This study was designed to enumerate regulatory T-cells (Tregs) and estimate transforming growth factor-β1 (TGF-β1) levels in type 1 diabetic (T1D) patients with respect to disease duration and associated autoimmune diseases.